Anti-CD47 antibodies and methods of use thereof
US11840553B2 · kind B2 · utility
0Cited by
27References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2018 |
| Grant date | Dec 12, 2023 |
| Priority date | — |
| Expiry date | Apr 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to monoclonal and/or monovalent antibodies that bind CD47. The invention relates to monoclonal and/or monovalent antibodies that bind CD19. The invention also relates to novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, where one of the binding sites is specific for CD47. The invention also relates to novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, where one of the binding sites is specific for CD19.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.